Epigenic secures funds to advance gene editing therapy

Epigenic Therapeutics has secured $20m in Series Angel and Pre-A funding to proceed with next-generation gene editing therapy.

Related Keywords

Michael Xue ,Bob Zhang ,Trinity Innovation Fund ,Kingray Capital ,Tigeryeah Capital ,Morningside Venture Capital ,Series Pre A ,Fountainbridge Capital ,Venture Capital ,Epigenic Therapeutics ,